Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer
recent articles
JelloX: Results of a Taiwan-based study are expected to be validated in a new collaboration with a major Japanese medical institution, assessing the higher sensitivity of 3D pathology over conventional sampling techniques across populations and...
Lunit: AI-powered model predicts EGFR mutations from H&E-stained slides, demonstrating robust performance across diverse clinical settings and helping overcome barriers to molecular testing in NSCLC SEOUL, South Korea, March 26,...
Check out this YouTube video showcasing an overview of FormaPath's nToto. Click here to view on YouTube. SOURCE:...
From Gestalt on LinkedIn: We have launched PathCloud®! Laboratories or individual pathologists who want to share images with colleagues without the need or investment of a full enterprise digital pathology deployment—this is a great...
PathAI to present key research advancing digital pathology and host a networking event, H&E by the Sea, on March 25th at 6:00 p.m. ET at Nautilus Pier 4 BOSTON, March 25, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered...
The University of Liverpool has signed a Memorandum of Understanding (MoU) with Roche Diagnostics UK and Ireland to advance research and innovation for improved health and community prosperity. The University is committed to addressing...
